Podcast Episodes
Back to Search
We take some questions
Why do companies care about their share price so much? Is Switzerland in danger of losing its banks? What would regime change in Venezuela do to glob…
3 months, 1 week ago
Three numbers that matter
Today on the show, Katie Martin and Rob Armstrong take a look at some revealing numbers about jobs, inflation and borrowing against the Treasuries ma…
3 months, 2 weeks ago
Gold, silver and crypto
Silver is on a tear this year, outperforming gold and even crypto. Today on the show, Rob Armstrong and Katie Martin look at the markets for substitu…
3 months, 2 weeks ago
Can 2026 match 2025?
What went right in 2025? What could go wrong in 2026? Recorded last week for the FT’s digital conference The Global Boardroom, Katie Martin and Rob A…
3 months, 3 weeks ago
Who gets to buy Warner Bros Discovery?
Netflix and Paramount are in a bidding war to take over Warner Bros Discovery and its historic collections of movies and television series. Today on …
3 months, 3 weeks ago
A satanic list of inflationary factors
Today on the show, Katie Martin and Rob Armstrong talk with special guest Adam Posen about the prospects for inflation and even a financial crisis. P…
3 months, 4 weeks ago
Bonds vs budgets
Mature economies such as France, the UK and the US are spending more than they take in. They make up the rest in borrowing. But how long can that las…
4 months ago
What are the hedge funds shorting?
Short interest in the market is rising. But what are the big players betting against? And what can investors learn from it? Today on the show, Katie …
4 months, 1 week ago
Nvidia's crazy day
In the morning, Nvidia’s earnings report seemed to have cured the market of its jitters about an artificial intelligence bubble. And then it didn’t. …
4 months, 1 week ago
Big deals in Big Pharma
The battle between Novo Nordisk and Pfizer to acquire Metsera is over. But is this merger a sign of strength or weakness for the industry? Today on t…
4 months, 2 weeks ago